Congratulations to Dr. Richard Oravec for starting the Sports Medicine Residency Program-St.Agnes Medical Center Fresno, California

• 举报此文章

John Nelson MD,FACC,FNLA,FASNC

John Nelson MD,FACC,FNLA,FASNC

Director at California Cardiovascular Institute

发布日期: 2024年9月24日

+ 关注

This is the only Sports Medicine Residency Program in the entire Central Valley of California

The diversity of experience for the Fellows is unparalleled.

See you tube video:

https://youtu.be/rTV1lpDXPes

要查看或添加评论，请登录

更多精彩文章

无上一项内容

• When looking at published CVOT's only Prescription Icosapent Ethyl added to Statin Therapy has been shown to Reduce Cardiovascular Mortality

  2024年4月14日

• Undertreatment of Elevated Triglycerides(Tg) in Patients with CVD-Saw a Patient this week with CAD/Carotid disease with LDL-C 44mg/dl and Tg 230mg/dl

  2024年2月15日

• I will be giving a Triglyceride Lecture at the 2024 Heart and Lung Institute Symposium on Saturday February 10th ,2024

  2024年2月6日

• NNT=11 !!!! REDUCE-IT ACS Just Published

  2024年1月22日

• AHA Abstract 18492: Cross-Sectional Analysis of Demographic and Clinical Characteristics of Patients Using Icosapent Ethyl,With a Focus on Patients wi

  2024年1月14日

• Icosapent Ethyl (Vascepa) Cost-Effective in REDUCE-IT USA-Confirmed what we predicted and see in the trenches

  2024年1月6日

• Pleiotropic effects of Eicosapentaenoic Acid Keep Mounting: Latest study in International Journal of Medical Sciences

  2023年12月18日

• ESC Abstract #84183First Descriptive Study of Demographic and Clinical Characteristics of US Patients Using Icosapent Ethyl: Cross-sectional analysis

  2023年11月18日

• Fresno State-Now Ranked 25th in US LBM Coaches Poll !!!!

  2023年11月6日

• The EPA/DHA therapy of 2 or 4 g/day did not significantly improve the high-risk features of coronary atherosclerotic plaques evaluated using CMR under

  2023年9月14日

无下一项内容

查看全部